Skip to main navigation Skip to search Skip to main content

Incidence of non-arteritic ischaemic optic neuropathy across completed phase 2, 3 and 4 trials evaluating the glucagon-like peptide-1 receptor agonists liraglutide and semaglutid

  • Tina Vilsbøll
  • , Lloyd Paul Aiello
  • , Cecilia Rönnbäck
  • , Michael Stellfeld
  • , M Larsen
Original languageEnglish
Article numberLBA 22
JournalDiabetologia
Volume68
Issue numberSuppl 1
Pages (from-to)S655
ISSN0012-186X
DOIs
Publication statusPublished - Oct 2025
Event61th EASD Annual Meeting: EASD 2025 - Wien, Austria
Duration: 15 Sept 2025 → 19 Sept 2025

Conference

Conference61th EASD Annual Meeting: EASD 2025
Country/TerritoryAustria
CityWien
Period15/09/2025 → 19/09/2025

Cite this